Peptide record

TPDB07256

Antibacterial Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07256
Antibacterial Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb dbAMP 3.0 CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Antifungal, Antiparasitic, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ALWKTLLKKVLKA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C74H130N18O15
RNDCEQGHIMFPSY
LK
1511.96
11.00
4
0
8
+4
-0.38
0.446
157.69
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
5500
3.64
1
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
4
L
4
K
0
M
0
F
0
P
0
S
1
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 4 K: 4 M: 0 F: 0 P: 0 S: 0 T: 1 W: 1 Y: 0 V: 1
Chemical Descriptors
13 reviewed residue count
C74H130N18O15 sequence-only estimate (linear, free termini)
1511.96 sequence-only estimate (linear, free termini)
11.00 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-0.38 sequence-only estimate (linear, free termini)
0.446 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

LC50
Hemolysis
50 µM
[Ref.15917541]LC50=50 µM against human red blood cells

Target

human red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
J Biol Chem. 2006 Apr 7 281(14):9432-9438.##Antimicrob Agents Chemother. 2005 Jun 49(6):2412-2420.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
57±3 µM
Hemolytic Cytotoxic
50% Hemolysis | 57±3 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
21.2±0.6 µM
Hemolytic Cytotoxic
50% Hemolysis | 21.2±0.6 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. | J Biol Chem | 2002
Evidence 4 Activity

Activity

14% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
14% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes. | Int J Antimicrob Agents | 2011
Evidence 5 Activity

Activity

50% Hemolysis
Toxicity
>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 6 Activity

Activity

50% Hemolysis
Toxicity
25±3 µM
Hemolytic Cytotoxic
50% Hemolysis | 25±3 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives. | Antimicrob Agents Chemother | 2006
Evidence 7 Activity

Activity

50% Hemolysis
Toxicity
6±0.5 µM
Hemolytic Cytotoxic
50% Hemolysis | 6±0.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives. | Antimicrob Agents Chemother | 2006
Evidence 8 Activity

Activity

50% Hemolysis
Toxicity
30±2 µM
Hemolytic Cytotoxic
50% Hemolysis | 30±2 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives. | Antimicrob Agents Chemother | 2006
Evidence 9 Activity

Activity

50% Hemolysis
Toxicity
80 µM
Hemolytic Cytotoxic
50% Hemolysis | 80 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 10 Activity

Activity

50% Hemolysis
Toxicity
75 µM
Hemolytic Cytotoxic
50% Hemolysis | 75 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
60 µM
Hemolytic Cytotoxic
50% Hemolysis | 60 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 12 Activity

Activity

50% Hemolysis
Toxicity
15 µM
Hemolytic Cytotoxic
50% Hemolysis | 15 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 13 Activity

Activity

50% Hemolysis
Toxicity
4.5 µM
Hemolytic Cytotoxic
50% Hemolysis | 4.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
9 µM
Hemolytic Cytotoxic
50% Hemolysis | 9 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. | Antimicrob Agents Chemother | 2005
Evidence 15 Activity

Activity

LC50
Toxicity
50 µM
Hemolytic
Hemolytic_activity: [Ref.15917541]LC50=50 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
J Biol Chem. 2006 Apr 7 281(14):9432-9438.##Antimicrob Agents Chemother. 2005 Jun 49(6):2412-2420.
Evidence 16 Hemolysis

Activity

50 µM
LC50
[Ref.15917541]LC50=50 µM against human red blood cells
Hemolysis

Target

human red blood cells

Source & Reference

HemoPI PD_Hemolysis
J Biol Chem. 2006 Apr 7 281(14):9432-9438.##Antimicrob Agents Chemother. 2005 Jun 49(6):2412-2420.
DRAMP4
PD_Hemolysis